(RKLB) Rocket Lab USA - Overview

Sector: Industrials | Industry: Aerospace & Defense | Exchange: NASDAQ (USA) | Market Cap: 78.587m USD | Total Return: 372% in 12m

Launch Vehicles, Spacecraft, Satellite Components, Software
Total Rating 52
Safety 60
Buy Signal 0.39
Aerospace & Defense
Industry Rotation: +12.9
Market Cap: 78.6B
Avg Turnover: 3.04B
Risk 3d forecast
Volatility106%
VaR 5th Pctl17.3%
VaR vs Median-0.71%
Reward TTM
Sharpe Ratio2.23
Rel. Str. IBD98.7
Rel. Str. Peer Group96.2
Character TTM
Beta3.158
Beta Downside1.922
Hurst Exponent0.498
Drawdowns 3y
Max DD55.49%
CAGR/Max DD3.89
CAGR/Mean DD9.19
EPS (Earnings per Share) EPS (Earnings per Share) of RKLB over the last years for every Quarter: "2021-03": -0.59, "2021-06": -0.21, "2021-09": -0.09, "2021-12": 0.01, "2022-03": -0.02, "2022-06": -0.08, "2022-09": -0.07, "2022-12": -0.08, "2023-03": -0.1, "2023-06": -0.1, "2023-09": -0.08, "2023-12": -0.1, "2024-03": -0.09, "2024-06": -0.08, "2024-09": -0.1, "2024-12": -0.1, "2025-03": -0.0737, "2025-06": -0.13, "2025-09": -0.03, "2025-12": -0.09, "2026-03": -0.07,
Last SUE: 0.36
Qual. Beats: 0
Revenue Revenue of RKLB over the last years for every Quarter: 2021-03: 18.192, 2021-06: 11.28, 2021-09: 5.287, 2021-12: 27.478, 2022-03: 40.703, 2022-06: 55.474, 2022-09: 63.057, 2022-12: 51.762, 2023-03: 54.895, 2023-06: 62.045, 2023-09: 67.661, 2023-12: 59.991, 2024-03: 92.767, 2024-06: 106.251, 2024-09: 104.808, 2024-12: 132.388, 2025-03: 122.569, 2025-06: 144.498, 2025-09: 155.08, 2025-12: 179.652, 2026-03: 200.348,
Rev. CAGR: 52.39%
Rev. Trend: 99.3%
Last SUE: 3.35
Qual. Beats: 1

Warnings

Share dilution 19.6% YoY

High Debt/EBITDA (7.1) with thin interest coverage (-23.0)

High Debt while negative Cash Flow

Interest Coverage Ratio -23.0 is critical

Altman Z'' -0.67 < 1.0 - financial distress zone

Choppy

Tailwinds

Rs Leader, Idiosyncratic Leader, Tailwind

Description: RKLB Rocket Lab USA

Rocket Lab USA Inc. (RKLB) is an end-to-end space company providing launch services and space systems for commercial and government clients. The company operates two primary segments: Launch Services, centered on the Electron small orbital rocket and the upcoming medium-lift Neutron vehicle, and Space Systems, which focuses on spacecraft manufacturing, components, and on-orbit management. By maintaining vertical integration, the company controls the production of critical subsystems and flight software, reducing reliance on external suppliers.

The aerospace sector is increasingly transitioning toward small-satellite constellations, which require the frequent, dedicated launch cadences that Rocket Labs business model is designed to support. Unlike traditional heavy-lift providers, the company’s focus on small-class vehicles allows for precise orbital insertion and shorter lead times for mission-specific payloads. You may find additional financial metrics and valuation models on ValueRay to further your analysis. Headquartered in Long Beach, California, the firm continues to expand its infrastructure for interplanetary missions and large-scale constellation deployments.

Headlines to Watch Out For
  • Neutron rocket development milestones determine long-term competitiveness against SpaceX Falcon 9
  • Space Systems segment revenue growth diversifies income beyond orbital launch services
  • High launch frequency of Electron rocket drives short-term cash flow and margins
  • Government and defense contract awards provide stable backlog and predictable revenue
  • Capital expenditure requirements for infrastructure expansion impact short-term profitability and liquidity
Piotroski VR-10 (Strict) 1.5
Net Income: -182.6m TTM > 0 and > 6% of Revenue
FCF/TA: -0.11 > 0.02 and ΔFCF/TA 2.90 > 1.0
NWC/Revenue: 205.7% < 20% (prev 80.84%; Δ 124.9% < -1%)
CFO/TA -0.06 > 3% & CFO -161.6m > Net Income -182.6m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 4.47 > 1.5 & < 3
Outstanding Shares: last quarter (605.4m) vs 12m ago 19.74% < -2%
Gross Margin: 36.56% > 18% (prev 0.27%; Δ 3.63k% > 0.5%)
Asset Turnover: 33.35% > 50% (prev 37.13%; Δ -3.78% > 0%)
Interest Coverage Ratio: -22.96 > 6 (EBITDA TTM -162.4m / Interest Expense TTM 9.25m)
Altman Z'' -0.67
A: 0.50 (Total Current Assets 1.80b - Total Current Liabilities 402.3m) / Total Assets 2.82b
B: -0.37 (Retained Earnings -1.06b / Total Assets 2.82b)
C: -0.10 (EBIT TTM -212.5m / Avg Total Assets 2.04b)
D: -1.91 (Book Value of Equity -1.06b / Total Liabilities 555.6m)
Altman-Z'' = -0.67 = B
Beneish M -3.40
DSRI: 0.42 (Receivables 75.0m/122.5m, Revenue 679.6m/466.0m)
GMI: 0.75 (GM 36.56% / 27.30%)
AQI: 1.02 (AQ_t 0.20 / AQ_t-1 0.20)
SGI: 1.46 (Revenue 679.6m / 466.0m)
TATA: -0.01 (NI -182.6m - CFO -161.6m) / TA 2.82b)
Beneish M = -3.40 (Cap -4..+1) = AA
What is the price of RKLB shares?

As of May 26, 2026, the stock is trading at USD 135.76 with a total of 32,862,100 shares traded.
Over the past week, the price has changed by +8.81%, over one month by +64.98%, over three months by +93.39% and over the past year by +372.04%.

Is RKLB a buy, sell or hold?

Rocket Lab USA has received a consensus analysts rating of 4.13. Therefore, it is recommended to buy RKLB.

  • StrongBuy: 7
  • Buy: 3
  • Hold: 5
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the RKLB price?
Analysts Target Price 100.8 -25.7%
Rocket Lab USA (RKLB) - Fundamental Data Overview as of 24 May 2026
Market Cap USD = 78.6b (78.6b USD * 1.0 USD.USD)
P/S = 115.641
P/B = 34.706
Revenue TTM = 679.6m USD
EBIT TTM = -212.5m USD
EBITDA TTM = -162.4m USD
Long Term Debt = 38.6m USD (from longTermDebt, last quarter)
 Short Term Debt = unknown (none)
 Debt = 237.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 100.1m
Net Debt = -1.15b USD (calculated: Debt 237.0m - CCE 1.38b)
Enterprise Value = 77.4b USD (78.6b + Debt 237.0m - CCE 1.38b)
Interest Coverage Ratio = -22.96 (Ebit TTM -212.5m / Interest Expense TTM 9.25m)
EV/FCF = -244.8x (Enterprise Value 77.4b / FCF TTM -316.3m)
FCF Yield = -0.41% (FCF TTM -316.3m / Enterprise Value 77.4b)
FCF Margin = -46.54% (FCF TTM -316.3m / Revenue TTM 679.6m)
Net Margin = -26.87% (Net Income TTM -182.6m / Revenue TTM 679.6m)
Gross Margin = 36.56% ((Revenue TTM 679.6m - Cost of Revenue TTM 431.2m) / Revenue TTM)
Gross Margin QoQ = 38.18% (prev 37.98%)
Tobins Q-Ratio = 27.46 (Enterprise Value 77.4b / Total Assets 2.82b)
Interest Expense / Debt = 3.90% (Interest Expense 9.25m / Debt 237.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -167.8m (EBIT -212.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.47 (Total Current Assets 1.80b / Total Current Liabilities 402.3m)
Debt / Equity = 0.10 (Debt 237.0m / totalStockholderEquity, last quarter 2.26b)
 Debt / EBITDA = 7.06 (negative EBITDA) (Net Debt -1.15b / EBITDA -162.4m)
 Debt / FCF = 3.62 (negative FCF - burning cash) (Net Debt -1.15b / FCF TTM -316.3m)
 Total Stockholder Equity = 1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.96% (Net Income -182.6m / Total Assets 2.82b)
RoE = -7.17% (Net Income TTM -182.6m / Total Stockholder Equity 2.55b)
RoCE = -8.22% (EBIT -212.5m / Capital Employed (Equity 2.55b + L.T.Debt 38.6m))
 RoIC = -10.49% (negative operating profit) (NOPAT -167.8m / Invested Capital 1.60b)
 WACC = 17.05% (E(78.6b)/V(78.8b) * Re(17.09%) + D(237.0m)/V(78.8b) * Rd(3.90%) * (1-Tc(0.21)))
Discount Rate = 17.09% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 95.56 | Cagr: 10.63%
 [DCF] Fair Price = unknown (Cash Flow -316.3m)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.36 | # QB: 0
Revenue Correlation: 99.31 | Revenue CAGR: 52.39% | SUE: 3.35 | # QB: 1
EPS current Quarter (2026-06-30): EPS=-0.08 | Chg30d=-28.43% | Revisions=-25% | Analysts=9
EPS next Quarter (2026-09-30): EPS=-0.07 | Chg30d=-38.19% | Revisions=-14% | Analysts=9
EPS current Year (2026-12-31): EPS=-0.27 | Chg30d=-20.18% | Revisions=-33% | GrowthEPS=+27.6% | GrowthRev=+50.8%
EPS next Year (2027-12-31): EPS=-0.04 | Chg30d=N/A | Revisions=+43% | GrowthEPS=+84.6% | GrowthRev=+40.1%
[Analyst] Revisions Ratio: +43%